BRD2 and male infertility: A meta-analysis evaluating the effect of follicle-stimulating hormone (FSH) therapy on DFI in male infertility reported a significant reduction in the mean DFI after treatment with exogenous FSH (4.24%; 95% CI 0.24-8.25%) (31).